Use of point-of-care lactate in the prehospital aeromedical environment.
Prehospital and Disaster Medicine · 2014-03-19 · Randomised trial
Abstract
INTRODUCTION: Lactate measurement has been used to identify critical medical illness and initiate early treatment strategies. The prehospital environment offers an opportunity for very early identification of critical illness and commencement of care. HYPOTHESIS: The investigators hypothesized that point-of-care lactate measurement in the prehospital aeromedical environment would: (1) identify medical patients with high mortality; (2) influence fluid, transfusion, and intubation; and (3) increase early central venous catheter (CVC) placement. METHODS: Critically ill, medical, nontrauma patients who were transported from September 2007 through February 2009 by University of Massachusetts (UMass) Memorial LifeFlight, a university-based emergency medical helicopter service, were eligible for enrollment. Patients were prospectively randomized to receive a fingerstick whole-blood lactate measurement on an alternate-day schedule. Flight crews were not blinded to results. Flight crews were asked to inform the receiving attending physician of the results. The primary endpoint was the ability of a high, prehospital lactate value [> 4 millimoles per liter (mmol/L)] to identify mortality. Secondary endpoints included differences in post-transport fluid, transfusion, and intubation, and decrease in time to central venous catheter (CVC) placement. Categorical variables were compared between groups by Fisher's Exact Test, and continuous variables were compared by t-test. RESULTS: Patients (N = 59) were well matched for age, gender, and acuity. In the lactate cohort (n = 20), mean lactate was 7 mmol/L [Standard error of the mean, SEM = 1]. Initial analysis revealed that prehospital lactate levels of ≥ 4 mmol/L did show a trend toward higher mortality with an odds ratio of 2.1 (95% CI, 0.3-13.8). Secondary endpoints did not show a statistically significant change in management between the lactate and non lactate groups. There was a trend toward decreased time to post-transport CVC in the non lactate faction. CONCLUSION: Prehospital aeromedical point-of-care lactate measurement levels ≥ 4 mmol/L may help stratify mortality. Further investigation is needed, as this is a small, limited study. The initial analysis did not find a significant change in post-transport management.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Helicopter & air ambulance · Mortality & survival · Point-of-care tests
Related articles
- Viscoelastic haemostatic assays in aeromedical transport. (Emerg Med Australas, 2020)
- Laboratory testing during critical care transport: point-of-care testing in air ambulances. (Clin Chem Lab Med, 2010)
- Implementation and challenges of portable blood gas measurements in air medical transport. (Clin Chem Lab Med, 2022)
- Reliability of Continuous Noninvasive Hemoglobin Monitoring in Healthy Participants During En Route Care Training. (Mil Med, 2024)
- Prehospital coagulation measurement by a portable blood analyzer in a helicopter emergency medical service (HEMS). (Am J Emerg Med, 2021)
- Impact of point-of-care biomarkers on the improvement of the predictive capacity of early warning scores in prehospital care: a systematic review and meta-analysis. (Emergencias, 2025)